2Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
3Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
4The TIMI study group.The thrombolysis in myocardial infarction (TIMI) trial;phase I findings.N Engl J Med,1985,312:932-936.
6Beers MH. The Merck Manual of Diagnosis and Therapy (18 nd Ed) [M]. Whitehouse NJ: Merck Research Laboratories, 2006: 1064- 1070.
7Balamuthusamy S, Arora R. Hematologic adverse effects of clopidogrel [J]. Am J Ther, 2007; 14: 106-112.
8Bougie DW, Wilker PR, Wuitschick ED,et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand - occupied GPⅡb/Ⅲa [ J ]. Blood, 2002 ; 100:2071 - 2076.
9Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update[ J]. Postgrad Med J,2007 ;83:575 - 582.
10Nikolsky E, Sadeghi HM, Effron MB, et al. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction [ J]. Am J Cardiol, 2005, 96(4) : 474 -481.
